<DOC>
	<DOC>NCT01401985</DOC>
	<brief_summary>A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation</brief_summary>
	<brief_title>A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>stable dose of opioids for at least 12 weeks before screening visit less than or equal to 5 spontaneous bowel movements for a 2 week period and experiencing at least one other symptom of constipation willing to stop laxatives and other bowel treatments; rescue laxative allowed Clinically significant condition or illness (other than the condition for which the pain medication was prescribed) Have participated in another clinical trial of an investigational drug 30 days prior to screening History of cancer treatment except adequately treated localized skin cancer within 5 years of screening History of chronic constipation prior to opioid therapy Females who are pregnant or breast feeding Have any condition that may affect drug absorption (e.g. previous GI surgery)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Opioid induced constipation</keyword>
	<keyword>OIC</keyword>
	<keyword>Constipation</keyword>
	<keyword>Opioid side effects</keyword>
	<keyword>morphine induced constipation</keyword>
</DOC>